Assessment of Safety of Autologous Regulatory T-cells in the Treatment of Systemic Sclerosis

dc.contributor.author	Malasheuskaya, A.
dc.contributor.author	Hancharou, A.
dc.contributor.author	Antonevich, N.
dc.contributor.author	Chyzh, K.
dc.contributor.author	Apanasovich, V.
dc.contributor.author	Reabzeva, T.
dc.contributor.author	Butoryna, I.
dc.contributor.author	Dubuske, L.
dc.date.accessioned	2025-05-12T07:20:20Z
dc.date.available	2025-05-12T07:20:20Z
dc.date.issued	2024
dc.identifier.uri	https://rep.bsmu.by/handle/BSMU/48827
dc.description	Assessment of Safety of Autologous Regulatory T-cells in the Treatment of Systemic Sclerosis / A. Malasheuskaya, A. Hancharou, N. Antonevich [et al.] // Journal of Allergy and Clinical Immunology. – 2024. – Vol. 153, iss. 2, suppl. [American academy of allergy, asthma & immunology Annual Meeting, Washington, USA, 23-26 Febrruary 2024 : progr. and abstr. of papers to be presented during sci. sess.]. – AB185.	ru_RU
dc.language.iso	en	ru_RU
dc.title	Assessment of Safety of Autologous Regulatory T-cells in the Treatment of Systemic Sclerosis	ru_RU
dc.type	Article	ru_RU